Standard
NovoCure Discloses Cyberattack Exposing Data of Over 1400 Patients Amid Rising Wave of Medtech Security Breaches
NovoCure, a global oncology company specializing in innovative tumor-treating field technology, has officially disclosed a significant cybersecurity breach that resulted in the unauthorized access and exposure of sensitive data belonging to patients, healthcare providers, and employees. In a formal filing with the Securities and Exchange Commission (SEC) on Tuesday, September 3, 2026, the company revealed…
